Funder: National Institutes of Health
Due Dates: April 4, 2025 | October 3, 2025 (Renewal/Resubmission/Revision) | Letters of Intent: March 5, 2025 | September 3, 2025 (30 days prior to application due date)
Funding Amounts: Up to $150,000 direct costs per year for up to 2 years; not to exceed the remaining duration of the parent P50 grant.
Summary: Supports revision applications from active NCI P50 centers to incorporate and validate novel NCI IMAT-supported technologies to accelerate cancer research.
Key Information: Only currently funded NCI P50 centers with at least one year left on the parent award are eligible; technology must be developed through the NCI IMAT program.